FAQ
Log In
Thursday 21st September 2017
News
 › 
 › 

Drugs recall

19th July 2010

The Medicines and Healthcare products Regulatory Agency has stated that the manufacturer LEO Laboratories has recalled "all remaining stock" of Sodium Fusidate 500mg.

The recall is due to contamination of some batches of the drug by glass particles. The intravenous infusion of the drug has been found to have particles which would be too big to get through a needle, but there is a risk that smaller particles could exist in some remaining stock of the drug.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2017